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infectious molecular clones of the human immunodeficiency virus type 2 (HIV-2) will be valuable tools for the study 
of regulatory gene functions and the development of an animal model for the human acquired immunodeficiency syn- 
drome (AIDS). To this end, we have cloned and sequenced a novel HIV-2 isolate, HIV-2sEN. One clone, designated MK6, 
is infectious for various human T-cell lines and for human and macaque peripheral blood lymphocytes (PBL), allowing 
molecular studies of HIV-2 infection and replication. Since MK6 is highly cytopathic in MT-2 and Molt-4 clone 8 cells, 
antiviral agents and neutralizing sera may be tested. Cluster analysis of HIV-l, HIV-2, and simian immunodeficiency 
virus (SIV) envand gag genes revealed that HIV-2BEN yielded the earliest node of phylogenetic divergence for all reported 
HIV-2 sequences. Noise analysis showed that, with the current data, no specification of any branching order can be 
made among the four groups of primate lentiviruses, HIV-l, HIV-21SIVSMMIMAC, SIVAGM, and SIVhnND. o wgo Academic 
Press, Inc. 
INTRODUCTION 
Like HIV-1 (Barr&Sinoussi eta/., 1983), HIV-2 (Clavel 
et al., 1986a) may cause characteristic AIDS symp- 
toms and fatal immunodeficiency (Clavel et al., 1987), 
but it has been suggested that HIV-2 often causes less 
severe disease (Marlink et a/., 1988). In rare cases, 
HIV-2 may also induce a state in which neurological 
symptoms predominate (Klemm et al., 1988). Phyloge- 
netically HIV-2 is related to SIV isolated from rhesus 
macaques (Macaca mulatta) (Daniel et a/., 1985) and 
sooty mangabeys (Cercocebus atys) (Fultz et al., 1986) 
and it has been suggested that HIV-2 and SIVMAc may 
have evolved from SIVsMM (Hirsch et al., 1989). In con- 
trast to HIV-1 which is only capable of infecting chim- 
panzees and gibbons, but without inducing disease 
(Alter et a/., 1984; Morrow et al., 1989), several SIV iso- 
lates cause AIDS-like symptoms in macaques (Mur- 
phey-Corb et al., 1986; Daniel et al., 1987; McClure 
et a/., 1989). Recently, it has been demonstrated that 
vaccination can prevent infection in monkeys (Desro- 
sieretal., 1989; Murphey-Corb eta/., 1989). Since HIV- 
2 infects macaques (Dormont et al., 1989; Stahl-Hen- 
nig et a/., submitted for publication) it could be of value 
in the establishment of an animal model for human 
AIDS. 
We have isolated a biologically active molecular 
clone of HIV-2BEN and studied its biological and immu- 
’ To whom requests for reprints should be addressed. 
nological features in human T-cell lines as well as in 
macaque and human PBL. We have also started to in- 
vestigate the infectivity of the molecular clone for ma- 
caques in order to establish an animal model for vacci- 
nation and therapeutic studies. The complete se- 
quencing of the proviral DNA made it possible to 
determine the phylogenetic position of HIV-2BEN in rela- 
tion to the other primate lentiviruses. 
MATERIALS AND METHODS 
Cloning and nucleotide sequence analysis 
The origin, isolation, and restriction mapping of HIV- 
2BEN has been described elsewhere (Klemm ef al., 
1988; Schneider et al., in press). A h phage library was 
constructed from the genomic DNA isolated from Molt- 
4 clone 8 cells infected with HIV-2BEN, as described for 
HIV-&~HZ (Franchini et al., 1989). About 3.5 X 10” re- 
combinant plaques were screened (T, = -25”) with 
the pROD4.8 and pSPE2 inserts (Clavel et a/., 1986b) 
as probes. Six positive clones were plaque purified and 
analyzed by restriction mapping (Fig. 1). A set of over- 
lapping restriction fragments of MK2 and MK6 was 
subcloned into the Ml 3mpl8 and Ml 3mpl9 vectors 
(Messing and Viera, 1982) and both strands of the HIV- 
2BEN genome were sequenced by the dideoxynucleo- 
tide chain termination method (Sanger et a/., 1977). 
The nucleic acid sequence data were submitted to the 
Los Alamos HIV Sequence Database (G. Myers). 
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FIG. 1. Genomic organization (A) and restriction site maps of the 
provirus (6) and of five HIV-2 BEN molecular clones(C). Restriction en- 
zymes are BarnHI (B), Bglll (Bg), EcoRl (E), HindIll (H), Hincll (Hc), Kpnl 
(K), Pstl (P), Pvull (Pv). Xhol (X), and Xbal (Xb). Cellular DNA se- 
quences are indicated by broken lines. EMBL-3 vector DNA is indi- 
cated by dotted lines. Stars indicate restriction site polymorphism 
among the molecular clones. The clone MK3 contains the same part 
of the proviral HIV-2BEN genome as MK2. 
Transfection of MK6 to human T-ceil lines 
About 3 X lo6 Molt-4 clone 8 or MT-2 cells were 
transfected with 10 pg MK6 phage DNA by the DEAE- 
dextran method (Sompayrac and Danna, 1981; Milman 
and Herzberg, 1981). The RT assay was performed ac- 
cording to standard procedures (Hoffmann et al., 
1985). 
Infection of human and macaque PBL 
For infection, 1 X 1 O6 PBL were incubated for 1 hr in 
ceil-free supernatant of MKG-transfected Molt-4 clone 
8 cells (RT activity 1 X lo6 cpm), washed twice with 
serum-free RPM11 640 (GIBCO-BRL, Karlsruhe, FRG), 
and cultivated with RPMI 1640 medium supplemented 
with 20% FCS (Seromed, Berlin, FRG) and 10% IL-2 
(Biotest Diagnostics, Dreieich, FRG). Six days after in- 
fection an equal number of fresh PBL was added and 
4 days later cocultivation with Molt-4 clone 8 cells was 
hr at 80,000 g. Protein (10 pg) from each pellet was 
separated by electrophoresis on 8-l 2% continuous 
gradient polyacrylamide gels and transferred to nitro- 
cellulose filters (Schleicher & SchUell, Dassel, FRG). 
Blots were developed using serum from a rhesus mon- 
key experimentally infected with HIV-2BEN and a rabbit 
antiserum against purified SIVAGMp24. 
Polymerase chain reaction (PCR) 
For PCR analysis (Ou et a/., 1988) 1 pg of cellular 
DNA from the cell cultures indicated or 0.1 ng MK6 
DNA was dispensed into 100 ~1 of reaction buffer (67 
mM Tris-HCI, pH 8.8; 16.6 mM (NH&SO,; 10 mlVI p- 
mercaptoethanol; 0.5% DMSO; 0.17 mg/ml BSA; 4 
mn/r MgC12); 50 pM of each primer 1 and 2; 2.5 U Taq 
polymerase (New England Biolabs); 300 &l dNTP 
(Pharmacia, Uppsala, Sweden) and subjected to 35 cy- 
cles of amplification using a Biomed PCR processor. 
One cycle consisted of 1.5 min at 95”, 2 min at 46”, 
and 1.5 min at 70”. The first denaturation step was pro- 
longed to 6.5 min and the 35th extension step, to 
7.5 min. DNA samples were separated on a 2% aga- 
rose gel. 
Sequence analysis of HIV-2BEN 
The phylogenetic tree was constructed using the hi- 
erarchial cluster method “average linkage.” The com- 
putations were done with the CLUSTAN software 
package (D. Wishart) on an IBM 3090. Pairwise Ham- 
ming distances (Hamming, 1950) in the purine/pyrimi- 
dine space were determined after alignment of the env 
and gag nucleotide sequences using the program GAP 
of the UWCG software package. Since deletions and 
insertions were excluded from the further computa- 
tions, a total of 1992 positions of the aligned env se- 
quences were analyzed. The height of the shaded area 
in Fig. 4A refers to the arithmetic average box dimen- 
sion in Fig. 4B. The exact geometry in the purine/pyrim- 
idine space was determined for the four env se- 
quences that are the most diverged (i.e., inhabiting 
overall the largest Hamming distances in the computed 
pair-distance matrix) using a method that combines 
both horizontal and vertical sequence analysis (Eigen 
et a/., 1988). The box dimensions as well as the protru- 
sion lengths are given in exact positions. All sequences 
except the HIV-2BEN and the HIV-1 23u (now called HIV- 
1 HAN2; Sauermann et al., in press) sequences were de- 




Western blot analysis 
For Western blotting (Towbin and Gordon, 1984), vi- 
rus from cell culture supernatants was pelleted for 1 
Molecular cloning and genomic organization 
of HIV-2sE,,, 
The restriction enzyme pattern of the six HIV-&, 
clones obtained (Fig. 1 C) is considerably different from 
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FIG. 2. BIological activity of MK6. (A) RT activrty in Molt-4 clone 8 
cells transfected with MK6. RT activity is monitored as [3’P]dGMP 
incorporation using poly(rC):oligo(dG) as the template primer. Inset: 
Syncytia formation in transfected Molt-4 clone 8 cells (B) Western 
blot analysrs of virus purified from the cell-free supernatant of Molt-4 
clone 8 (lane 1) and MT-2 (lane 2) cells transfected with MK6. In lane 
3 protein of the wild-type HIV-ZBEN virus was separated; K, virus has 
been harvested from the supernatant of mock-transfected MT-2 cells 
with high background RT. Left, a rabbit antiserum to purified SIVAGM 
p24 and, right, a serum from a rhesus monkey experimentally in- 
fected with HIV-2BEN was used. 
those of previously analyzed HIV-2 proviruses (Guy- 
ader et al., 1987; Zagury et a/., 1988; Franchini et a/., 
1989; Kong et al., 1988; Kijhnel et al., 1989). The com- 
plete proviral HIV-2 BEN sequence of 10.359 nucleotides 
was obtained from the clones MK2 (bases 1903 to 
5857 and 7293 to 10359) and MK6 (bases 1 to 1902, 
5858to7292,and9132to10359).The1227basesof 
the 3’ region of MK2 and MK6 differed only in four 
bases. In genetic organization, HIV-2sEr, (Fig. 1A) is 
similar to other HIV-2 isolates (Guyader et al., 1987; 
Zagury et a/., 1988; Franchini et al., 1989). A detailed 
analysis of the HIV-2BEN sequence will be published 
elsewhere (Kirchhoff et al., submitted for publication). 
MK6 is infectious in human T-cell lines 
Eleven days after transfection of Molt-4 clone 8 and 
MT-2 cells with MK6 DNA syncytia formation occurred 
in both cell lines, and high RTactivitywas present in the 
cell culture supernatants (Fig. 2A). The viral proteins 
gpl60, gpl20, gp42, ~24, and pl8 could be detected 
in the respective culture supernatants (Fig. 2B). South- 
ern blot analysis revealed that for both cell lines the 
amount of integrated proviral MK6 DNA considerably 
exceeded that detected after infection of the same 
ceils with the original HIV-2BEN isolate (data not shown). 
Since the permanent production of MK6 virus readily 
caused cell death, transfected cultures had to be sup- 
plemented with uninfected cells every 2 to 3 days. In 
one MKG-transfected Molt-4 clone 8 cell culture nei- 
ther RT activity nor cytopathic effects were observed 
TABLE 1 
INFECTIVITY OF MK6 FOR HUMAN T-CELL LINES, 
AND HUMAN AND MACAQUE PBL 
Cell line 
Peak 
Day of RT activity Maximal 
maximal RT (pmol dGMP activity in 
after infection incorp. ml-‘) uninfected cells 
Molt-4 clone 8 9 110.4 0.9 
MT-2 10 60.2 15.8 
CEM 23 9.4 0.6 
HUT-78 37 5.5 0.7 
Jurkat 16 3.1 0.6 
Human PBL 18 6.8 0.1 
Cynomolgus PBL 7a 6.4 0.2 
Rhesus PBL 70 7.0 0.2 
Note. Human T-cell lanes were infected with 1 x 10” cpm RT activ- 
ity of MK6 virus as described for the infection of PBL under Materials 
and Methods. In MT-2 cell supernatants high background RT activity 
was measured owing to the fact that this cell line carries the HTLV- 
1 provirus (Harada eta/., 1985). 
a Macaque PBL were cocultivated with Molt-4 clone 8 ten days 
after infection since they were too sensitive for longer independent 
cultivation. Therefore, the RT values shown may not represent the 
real peak activity. All infections were repeated two to five times with 
similar results. 
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primer 1 BamHI 
~~ljcGGAGCAGfGGTGGGATAACTACTGGCAAGTGACA~~~AGAGTOGGACTTTGT~ 
“probe” HincII primer 2 ___ -____ 
TCTACC~~b;C-~ACiGGTCA~~~TTfAACCTAGTA~GAGATCCTAfACCAG~~~~ 
Molt-4cl.8 Molt-4cl.8 MU6 Molt-4cl.8 rhesus cynomolgus 
Ben infected uninfected +MK6 +MK6 +MK6 
bp Ml234 Ml234 Ml234 Ml234 Ml234 Ml 234 
FIG. 3. Detection of proviral sequences by PCR. Above, the amplified DNA sequence of the HIV-2 BEN genome is noted. The primer sequences, 
the radioactively labeled probe, and restriction enzyme recognition sites used are indicated. Middle, agarose gels with amplified DNAfragments 
and bottom Southern blots of the same gels. (M) Marker (bX174Haelll digested, New England Biolabs Inc., Beverley, USA); lane 1, undigested 
DNA; 20.~1 aliquots of amplified DNA were digested with BarnHI (lane 2), Hincll (lane 3), and BarnHI and Hincll together(lane 4). 
6 weeks after transfection. However, substantial 
amounts of proviral DNA were still present after 2 
months of culture and the addition of uninfected cells 
leads to renewed giant cell formation and virus release. 
To examine the cell tropism of MK6, Jurkat, CEM-T4, 
and HUT-78 cells were infected with culture superna- 
tant from transfected Molt-4 clone 8 cells. In these 
three cell lines MK6 replicated less efficiently than in 
Molt-4 clone 8 or MT-2 cells (Table 1). In contrast to 
infected MT-2 and Molt-4 clone 8 cells, where the RT 
peak was reached 9 to 10 days after infection, the HUT- 
78, CEM-T4, and Jurkat cell lines showed maximal RT 
values 2 to 5 weeks after infection (Table 1). Southern 
blot and PCR analysis revealed the presence of rela- 
tively low amounts of MK6 provirus in the host cell ge- 
nomes (data not shown). Furthermore, little or no cyto- 
pathic effects were observed in these three cell lines. 
MK6 is highly infectious for macaque 
and human PBL 
Eighteen days after infection of human PBL peak RT 
activity was present in the cell-free supernatants (Table 
1). After cocultivation with uninfected Molt-4 clone 8 
cells giant cell formation and high RT values of about 
60 pmol dGMP incorporation per milliliter of superna- 
tant were observed. The infection of macaque PBLwith 
MK6 proceeds much faster. Seven days after infection 
of rhesus and fascicularis macaque PBL, RT activities 
comparable to the peak activity observed in infected 
human PBL culture supernatants were detected in 
both cultures (Table 1). Since macaque PBL were very 
sensitive, subsequent cocultivation with Molt-4 clone 8 
cells was necessary. About 10 days later the RT values 
increased to about 75 pmol dGMP incorporated per 
milliliter of supernatant. MK6 proviral DNA in these cul- 
tures was detected by PCR analysis (Fig. 3). 
The phylogenetic position of HIV-2sEN 
To investigate the phylogenetic position of HIV-2BEN 
relative to other HIV-2 and SIV isolates, evolutionary 
trees were constructed from the DNA sequences of 
the env (Fig. 4A) and gag (not shown) genes. The 
branching order is consistent for both genes and also 
for different methods of evaluation of the pair-distance 
matrix (i.e., using transversions only, as well as both 
weighted and unweighted transitions and transver- 
sions). The diagram indicates that HIV-2BEN has 
branched off the main stem earlier than the HIV-2 iso- 
lates previously described. From the groups HIV-l, 
HIV-2, and SIV, the four sequences furthest diverged 
from their assumed common precursor were com- 
pared by using a method of noise analysis (Eigen et 
a/,, 1988) (Fig. 4B). The diagram reveals a bundle-like 
topology since the three box dimensions are of almost 
equal magnitude. All four groups of HIV and SIV (HIV- 
1, HIV-2/SIVSMM,MAC, SIVAGM , and SIV,,,) branch off in- 












FIG. 4. Comparative sequence analysis of HIV-l, HIV-2, and SIV 
based on the env DNA sequences in the purine/pyrimidine space 
(1992 base positions considered). (A) Phylogenetic tree derived by 
cluster analysis. In the scale the number of diverged base positions 
is given. Therefore, the distance in sequence positions between any 
two isolates is twice the distance along the ordinate to the connect- 
ing node. (6) Exact geometry of the four most diverged sequences. 
Numbers refer to exact positions as described by Eigen era/. (1988). 
side the shaded area in Fig. 4B. We therefore conclude 
that there exists a common node for the four groups, 
which lies within the box. The classical tree construc- 
tion methods usually yield a definite order of even the 
early branching nodes (Smith eta/., 1988; Tsujimoto et 
a/., 1989). However, the present analysis shows that 
due to noise accumulation, the existing data are not 
sufficient to specify the early branching order of HIV-l, 
HIV-2/SIVSMM,MAC, SIVAGM, and SIVMVIND. 
DISCUSSION 
In the present study we describe the biological prop- 
erties and the phylogenetic position of a new HIV-2 pro- 
viral clone. 
The varying biological properties of HIV-2 isolates, 
such as replication rates, cytopathogenicity, and cell 
tropism may have relevance to the different degrees of 
pathogenicity in humans (Kong et al., 1988; Kiihnel et 
a/., 1989). Another HIV-2 isolate from a patient with 
neurological disorders, HIV-2,,rg4 (Ktihnel et al., 1989), 
grows slowly with little or no syncytia formation in HUT- 
78 cells. Our data show that those findings could not 
be generalized for other human T-cell lines. 
Inexpensive and efficient animal models are neces- 
saryfor the development of protective vaccines against 
HIV infection. To date, only macaques infected with 
various SIV isolates have developed AIDS-like symp- 
toms (Daniel et a/., 1987; McClure el al., 1989) while 
the pathogenicity of HIV-2 for macaques is still a sub- 
ject of discussion (Letvin et al., 1987; Dormont et al., 
1989). Nevertheless, clinical alterations in HIV-2-in- 
fected macaques have been described (Dormont eta/., 
1989) and the duration of the animal studies con- 
ducted so far may be too short to exclude a subse- 
quent appearance of AIDS-like symptoms. Therefore, 
the development of an animal model with a well-char- 
acterized molecular clone of a human virus, highly re- 
lated to SIVSMM,MAC, will be of great interest. Of the mo- 
lecular HIV-2 clones described previously (Naidu et a/., 
1988; Zagury et al., 1988), only the HIV-2SB,,ISY clone 
(Franchini et al., 1989) has been reported to be infec- 
tious for macaque PBL and macaques, though the data 
have yet to be published. 
We have shown that MK6 reproducibly replicates in 
the PBL of rhesus and cynomolgus macaques. Prelimi- 
nary data has proven that MK6 is also infectious for 
cynomolgus monkeys. Inoculation of cell-free MK6 vi- 
rus in two animals led to seroconversion 4 weeks post- 
inoculation and viremia in one animal (data not shown). 
The MK6 clone has several interesting biological fea- 
tures and provides us with many opportunities for fu- 
ture study. It is highly cytopathic and blocks prolifera- 
tion in Molt-4 clone 8 and MT-2 cells. Therefore, antivi- 
ral agents and neutralizing sera can be tested in vitro. 
Since MK6 is infectious not only in human and ma- 
caque PBL, but also for macaques, we will investigate 
the influence of the negative regulatorynefprotein (Guy 
et al., 1987) on the in vitro and in viva pathogenicity of 
HIV-2. To examine the genetic evolution of the HIV-2 
genome, we have begun to determine the in viva and 
in vitro mutation rates of MK6 by PCR analysis. 
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